Please assess the completion status of the following clinical trial:

Trial Title: Medication Abortion Via Pharmacy Dispensing

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Patient Inclusion Criteria:~* Women seeking medication abortion through 70 days gestation~* Eligible for Mifeprex® at a study clinical site~* English or Spanish speaking~* Willing and able to participate in the study, including willing to go to the study pharmacy to obtain mifepristone~Patient Exclusion Criteria:~* Not pregnant~* Not seeking medication abortion~* Under the age of 15~* Contraindications for medication abortion~  * All pharmacists providing services at one of the study pharmacies during the study are eligible for the pharmacist survey and interview.

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Medication abortion patients (Type: EXPERIMENTAL): Oral mifepristone 200 mg, followed by misoprostol 800 mcg administered buccally (at 24-48 hours following mifepristone) or vaginally (as soon as 6 hours following mifepristone)
- Pharmacists (Type: OTHER): Pharmacists providing services at one of the study pharmacies during the study

Based on this trial design, predict the completion outcome and termination type (if applicable).